US Stock MarketDetailed Quotes

Cadrenal Therapeutics (CVKD)

Watchlist
  • 4.850
  • +0.040+0.83%
Close Apr 16 16:00 ET
  • 4.850
  • 0.0000.00%
Post 20:01 ET
12.16MMarket Cap-0.73P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Cadrenal Therapeutics (CVKD) Balance Sheet

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Assets
Current assets
Cash, cash equivalents and short term investments
-59.99%4.01M
-59.99%4.01M
-11.55%3.86M
10.59%5.57M
11.72%7.34M
19.23%10.02M
19.23%10.02M
-52.09%4.36M
55.96%5.04M
63.00%6.57M
-Cash and cash equivalents
-59.99%4.01M
-59.99%4.01M
-11.55%3.86M
10.59%5.57M
11.72%7.34M
19.23%10.02M
19.23%10.02M
-52.09%4.36M
55.96%5.04M
63.00%6.57M
Receivables
-86.64%5.1K
-86.64%5.1K
--12.79K
--19.04K
--24.66K
2.43%38.15K
2.43%38.15K
----
----
----
-Accrued interest receivable
-86.64%5.1K
-86.64%5.1K
--12.79K
--19.04K
--24.66K
2.43%38.15K
2.43%38.15K
----
----
----
Prepaid assets
----
----
-39.48%116.02K
52.53%358.36K
95.94%575.61K
-19.40%42.26K
-19.40%42.26K
13.70%191.71K
-18.80%234.95K
-28.51%293.77K
Current deferred assets
636.19%106.34K
636.19%106.34K
-22.28%90.84K
-86.08%23.86K
-94.96%8.45K
--14.45K
--14.45K
--116.88K
--171.38K
--167.84K
Other current assets
373.63%200.14K
373.63%200.14K
-39.48%116.02K
52.53%358.36K
95.94%575.61K
-19.40%42.26K
-19.40%42.26K
13.70%191.71K
-18.80%234.95K
-28.51%293.77K
Total current assets
-57.29%4.32M
-57.29%4.32M
-12.69%4.08M
9.71%5.97M
13.04%7.94M
19.08%10.11M
19.08%10.11M
-49.64%4.67M
54.68%5.44M
58.31%7.03M
Non current assets
Net PPE
-25.49%5.17K
-25.49%5.17K
90.27%5.73K
-56.69%4.28K
-71.84%4.68K
-70.18%6.94K
-70.18%6.94K
-89.89%3.01K
-72.65%9.88K
-57.41%16.61K
-Gross PPE
-25.49%5.17K
-25.49%5.17K
----
-56.69%4.28K
----
-70.18%6.94K
-70.18%6.94K
-89.89%3.01K
-72.65%9.88K
-57.41%16.61K
Other non current assets
-42.85%2.17K
-42.85%2.17K
-42.85%2.17K
-42.85%2.17K
0.00%3.79K
0.00%3.79K
0.00%3.79K
0.00%3.79K
0.00%3.79K
0.03%3.79K
Total non current assets
-31.62%7.34K
-31.62%7.34K
16.07%7.9K
-52.85%6.44K
-58.48%8.47K
-60.35%10.74K
-60.35%10.74K
-79.74%6.8K
-65.74%13.67K
-52.33%20.4K
Total assets
-57.26%4.33M
-57.26%4.33M
-12.64%4.09M
9.55%5.98M
12.84%7.95M
18.83%10.12M
18.83%10.12M
-49.75%4.68M
53.33%5.46M
57.26%7.05M
Liabilities
Current liabilities
Payables
-56.69%650.66K
-56.69%650.66K
23.61%614.13K
17.92%895.61K
219.30%1.28M
797.97%1.5M
797.97%1.5M
250.72%496.82K
872.01%759.52K
234.85%400.37K
-accounts payable
-56.69%650.66K
-56.69%650.66K
23.61%614.13K
17.92%895.61K
219.30%1.28M
797.97%1.5M
797.97%1.5M
250.72%496.82K
872.01%759.52K
234.85%400.37K
Current accrued expenses
-5.02%204.12K
-5.02%204.12K
72.38%266.58K
-6.59%242.47K
-40.48%137.41K
410.79%214.92K
410.79%214.92K
273.65%154.65K
597.04%259.58K
160.51%230.87K
Current debt and capital lease obligation
----
----
----
----
----
----
----
-91.07%2.23K
-63.45%8.8K
-34.52%15.17K
-Current capital lease obligation
----
----
----
----
----
--0
--0
-91.07%2.23K
-63.45%8.8K
-34.52%15.17K
Current liabilities
-40.83%1.59M
-40.83%1.59M
6.77%1.35M
14.65%1.68M
114.89%1.84M
224.59%2.68M
224.59%2.68M
124.81%1.27M
291.37%1.46M
113.21%856.32K
Non current liabilities
Total non current liabilities
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total liabilities
-40.83%1.59M
-40.83%1.59M
6.77%1.35M
14.65%1.68M
114.89%1.84M
224.59%2.68M
224.59%2.68M
123.92%1.27M
282.38%1.46M
105.45%856.32K
Shareholders'equity
Share capital
31.20%2.34K
31.20%2.34K
66.86%2.06K
-87.47%2.01K
-88.07%1.91K
105.30%1.78K
105.30%1.78K
-90.52%1.23K
36.56%16.01K
36.56%16.01K
-common stock
31.20%2.34K
31.20%2.34K
66.86%2.06K
-87.47%2.01K
-88.07%1.91K
105.30%1.78K
105.30%1.78K
-90.52%1.23K
36.56%16.01K
36.56%16.01K
-Preferred stock
--0
--0
--0
--0
--0
--0
--0
--0
----
----
Retained earnings
-51.46%-38.96M
-51.46%-38.96M
-66.80%-35.92M
-73.76%-33.24M
-76.69%-29.57M
-70.67%-25.72M
-70.67%-25.72M
-54.63%-21.54M
-48.38%-19.13M
-40.77%-16.73M
Paid-in capital
25.74%41.7M
25.74%41.7M
54.95%38.65M
62.45%37.53M
55.73%35.68M
45.68%33.16M
45.68%33.16M
10.09%24.95M
43.90%23.1M
43.72%22.91M
Total stockholders'equity
-63.19%2.74M
-63.19%2.74M
-19.85%2.73M
7.68%4.3M
-1.28%6.11M
-3.29%7.44M
-3.29%7.44M
-60.98%3.41M
25.70%3.99M
52.32%6.19M
Total equity
-63.19%2.74M
-63.19%2.74M
-19.85%2.73M
7.68%4.3M
-1.28%6.11M
-3.29%7.44M
-3.29%7.44M
-60.98%3.41M
25.70%3.99M
52.32%6.19M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Assets
Current assets
Cash, cash equivalents and short term investments -59.99%4.01M-59.99%4.01M-11.55%3.86M10.59%5.57M11.72%7.34M19.23%10.02M19.23%10.02M-52.09%4.36M55.96%5.04M63.00%6.57M
-Cash and cash equivalents -59.99%4.01M-59.99%4.01M-11.55%3.86M10.59%5.57M11.72%7.34M19.23%10.02M19.23%10.02M-52.09%4.36M55.96%5.04M63.00%6.57M
Receivables -86.64%5.1K-86.64%5.1K--12.79K--19.04K--24.66K2.43%38.15K2.43%38.15K------------
-Accrued interest receivable -86.64%5.1K-86.64%5.1K--12.79K--19.04K--24.66K2.43%38.15K2.43%38.15K------------
Prepaid assets ---------39.48%116.02K52.53%358.36K95.94%575.61K-19.40%42.26K-19.40%42.26K13.70%191.71K-18.80%234.95K-28.51%293.77K
Current deferred assets 636.19%106.34K636.19%106.34K-22.28%90.84K-86.08%23.86K-94.96%8.45K--14.45K--14.45K--116.88K--171.38K--167.84K
Other current assets 373.63%200.14K373.63%200.14K-39.48%116.02K52.53%358.36K95.94%575.61K-19.40%42.26K-19.40%42.26K13.70%191.71K-18.80%234.95K-28.51%293.77K
Total current assets -57.29%4.32M-57.29%4.32M-12.69%4.08M9.71%5.97M13.04%7.94M19.08%10.11M19.08%10.11M-49.64%4.67M54.68%5.44M58.31%7.03M
Non current assets
Net PPE -25.49%5.17K-25.49%5.17K90.27%5.73K-56.69%4.28K-71.84%4.68K-70.18%6.94K-70.18%6.94K-89.89%3.01K-72.65%9.88K-57.41%16.61K
-Gross PPE -25.49%5.17K-25.49%5.17K-----56.69%4.28K-----70.18%6.94K-70.18%6.94K-89.89%3.01K-72.65%9.88K-57.41%16.61K
Other non current assets -42.85%2.17K-42.85%2.17K-42.85%2.17K-42.85%2.17K0.00%3.79K0.00%3.79K0.00%3.79K0.00%3.79K0.00%3.79K0.03%3.79K
Total non current assets -31.62%7.34K-31.62%7.34K16.07%7.9K-52.85%6.44K-58.48%8.47K-60.35%10.74K-60.35%10.74K-79.74%6.8K-65.74%13.67K-52.33%20.4K
Total assets -57.26%4.33M-57.26%4.33M-12.64%4.09M9.55%5.98M12.84%7.95M18.83%10.12M18.83%10.12M-49.75%4.68M53.33%5.46M57.26%7.05M
Liabilities
Current liabilities
Payables -56.69%650.66K-56.69%650.66K23.61%614.13K17.92%895.61K219.30%1.28M797.97%1.5M797.97%1.5M250.72%496.82K872.01%759.52K234.85%400.37K
-accounts payable -56.69%650.66K-56.69%650.66K23.61%614.13K17.92%895.61K219.30%1.28M797.97%1.5M797.97%1.5M250.72%496.82K872.01%759.52K234.85%400.37K
Current accrued expenses -5.02%204.12K-5.02%204.12K72.38%266.58K-6.59%242.47K-40.48%137.41K410.79%214.92K410.79%214.92K273.65%154.65K597.04%259.58K160.51%230.87K
Current debt and capital lease obligation -----------------------------91.07%2.23K-63.45%8.8K-34.52%15.17K
-Current capital lease obligation ----------------------0--0-91.07%2.23K-63.45%8.8K-34.52%15.17K
Current liabilities -40.83%1.59M-40.83%1.59M6.77%1.35M14.65%1.68M114.89%1.84M224.59%2.68M224.59%2.68M124.81%1.27M291.37%1.46M113.21%856.32K
Non current liabilities
Total non current liabilities --0--0--0--0--0--0--0--0--0--0
Total liabilities -40.83%1.59M-40.83%1.59M6.77%1.35M14.65%1.68M114.89%1.84M224.59%2.68M224.59%2.68M123.92%1.27M282.38%1.46M105.45%856.32K
Shareholders'equity
Share capital 31.20%2.34K31.20%2.34K66.86%2.06K-87.47%2.01K-88.07%1.91K105.30%1.78K105.30%1.78K-90.52%1.23K36.56%16.01K36.56%16.01K
-common stock 31.20%2.34K31.20%2.34K66.86%2.06K-87.47%2.01K-88.07%1.91K105.30%1.78K105.30%1.78K-90.52%1.23K36.56%16.01K36.56%16.01K
-Preferred stock --0--0--0--0--0--0--0--0--------
Retained earnings -51.46%-38.96M-51.46%-38.96M-66.80%-35.92M-73.76%-33.24M-76.69%-29.57M-70.67%-25.72M-70.67%-25.72M-54.63%-21.54M-48.38%-19.13M-40.77%-16.73M
Paid-in capital 25.74%41.7M25.74%41.7M54.95%38.65M62.45%37.53M55.73%35.68M45.68%33.16M45.68%33.16M10.09%24.95M43.90%23.1M43.72%22.91M
Total stockholders'equity -63.19%2.74M-63.19%2.74M-19.85%2.73M7.68%4.3M-1.28%6.11M-3.29%7.44M-3.29%7.44M-60.98%3.41M25.70%3.99M52.32%6.19M
Total equity -63.19%2.74M-63.19%2.74M-19.85%2.73M7.68%4.3M-1.28%6.11M-3.29%7.44M-3.29%7.44M-60.98%3.41M25.70%3.99M52.32%6.19M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +6.33%
Sample Name
Sample Code
 +4.40%
Sample Name
Sample Code
 +3.43%
4
United States Gasoline Fund Lp
UGA
+0.46%
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
-1.17%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +17.08%
Sample Name
Sample Code
 +16.18%
Sample Name
Sample Code
 +15.82%
4
Baidu
BIDU
+15.52%
5
Zai Lab
ZLAB
+13.31%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Trump stated on the 15th that the US-Iran war is 'about to end,' with an agreement expected to be reached before the end of April. However, Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -